InvestorsHub Logo
Followers 0
Posts 3
Boards Moderated 0
Alias Born 08/11/2017

Re: fred198484 post# 16773

Monday, 08/21/2017 6:17:15 PM

Monday, August 21, 2017 6:17:15 PM

Post# of 232273
Don't you think investing in a treatment idea and regimen that will revolutionize how HIV is handled is worth it. Let's look at the facts. The drug is effective. FDA thinks so as do some of their preliminary results with side effects being no more terrible than most prescription drugs available and used for the treatment of HIV. The market for something like this is HUGE, and with the convenience on not having to take a cocktail of pills constitutively patients will want it too. Often times patients are putting excess strain on their already failing livers to metabolize the daily consumption of their antivirals. The importance of a once a week therapy vs. once daily therapy is much deeper than just sheer convenience. Lastly the show doesn't stop here because antibody therapies are being studied extensively in the treatment of other detrimental diseases such as cancer. I'm not buying shares in the company because I'm worried about them diluting their share price in the short term to raise capital. I'm not saying you're wrong either. I'm buying shares because of the POTENTIAL this drug has. 3 years down the line IF it comes to market I won't give a second thought to how the company was managed at less than a dollar share price.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News